Galunisertib
id:
galunisertib-237-17695664
title:
Galunisertib
text:
Galunisertib (LY2157299) is a small molecular experimental cancer drug previously in development by Eli Lilly. It is a TGF-b inhibitor. Development of galunisertib by Eli Lilly was discontinued in January 2020. Galunisertib was investigated in a phase II trial for treatment of hepatocellular carcinoma. Pre-clinically, combination of galunisertib with PD-L1 blockade resulted in improved tumor growth inhibition.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Galunisertib
date created:
date modified:
2023-12-03T18:40:58Z
main entity:
{"identifier":"Q27077768","url":"https://www.wikidata.org/entity/Q27077768"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b9/Galunisertib.svg","width":1415,"height":860}
fields total:
13
integrity:
15